Taiwan Liposome Company Nearing IPO After Round Of Financing
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - A cash injection from a U.S. venture capital firm may help a Taiwanese developer of drug delivery systems better compete on a global scale as it moves towards an initial public offering